Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Lejeune P, Cruciani V, Berg-Larsen A, Schlicker A, Mobergslien A, Bartnitzky L, Berndt S, Zitzmann-Kolbe S, Kamfenkel C, Stargard S, Hammer S, Jørgensen JS, Jackerott M, Nielsen CH, Schatz CA, Hennekes H, Karlsson J, Cuthbertson AS, Mumberg D, Hagemann UB.
Lejeune P, et al.
J Immunother Cancer. 2021 Oct;9(10):e002387. doi: 10.1136/jitc-2021-002387.
J Immunother Cancer. 2021.
PMID: 34615703
Free PMC article.